Clinical trial
Treatment of the Anemia of Myelodysplastic Syndromes by the Association of…
NCT00437450 · Groupe Francophone des Myelodysplasies, Other · Unknown status
Key facts
| NCT number | NCT00437450 |
|---|---|
| Title | Treatment of the Anemia of Myelodysplastic Syndromes by the Association of Epoetin Beta and All Trans Retinoic Acid |
| Official title | Treatment of the Anemia of Myelodysplastic Syndromes by the Association of Epoetin Beta and All Trans Retinoic Acid |
| Lead sponsor | Groupe Francophone des Myelodysplasies, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Anemia in Myelodysplastic Syndromes |
| Intervention type | Drug |
| Interventions | Epoetin/Atra |
| Enrollment | 99 |
| Start date | Oct 1, 2004 |
| Completion | Sep 1, 2005 |
| First posted | Feb 21, 2007 |
| Last update posted | Nov 18, 2009 |
| Countries | France |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: